Barely Significant
← all excerpts

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.

Mol Genet Genomic Med · 2019 · PMC6625124 · PMID 31131560

2
hedged sentences
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.